In connection with the ongoing Ebola epidemic in Africa, a new study describing an mRNA vaccine against the pathogen of this highly fatal infection is worth noting. In animal models, it elicited a strong immune response and protected against fatal infection. Denying its efficacy and safety. (translated)

